Form 4: Prime Medicine Executive Transfers 250,000 Shares to Spouse for Estate Planning

Keith Michael Gottesdiener, President and CEO of Prime Medicine, transferred 250,000 shares of common stock to his spouse for estate planning purposes on June 5, 2024.

Summary

• On June 5, 2024, Keith Michael Gottesdiener, President and CEO of Prime Medicine, transferred 250,000 shares of Prime Medicine common stock to his spouse.
• The transfer was conducted for bona fide estate planning purposes and involved no consideration.
• Following the transaction, Gottesdiener directly owns 2,310,837 shares.
• Gottesdiener also indirectly owns 277,166 shares through his spouse, 455,334 shares through a trust for which certain of the Reporting Person's family member is a trustee, and 1,317,741 shares through a trust for which the Reporting Person's spouse and certain of the Reporting Person's family member are co-trustees.
• Gottesdiener disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest therein.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to a stock transfer for estate planning purposes, which is neutral in sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This particular filing reflects personal estate planning rather than a strategic shift in the company's direction.

Related Party Transactions

• The transfer of 250,000 shares to Gottesdiener's spouse is a related party transaction.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on stakeholders as it is a personal estate planning matter.

Key Dates